Cancer Research UK main site
  • Replies 0 replies
  • Views 26 views
  • Users 0 members are here

Cemiplimab (Libtayo)

xxHHxx
Offline

Hi,

Could you confirm that Libtayo has now been authorised for general use on the NHS for reccurrent cervical cancer and can be given irrespective of PDL1 expression ? 

Speak to a nurse

Quick links

Follow us

Registered with Fundraising Regulator (logo)
Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.